Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function
<p>Abstract</p> <p>Background</p> <p>The main hypothesis of this study is that neutral pH, low glucose degradation product (GDP) peritoneal dialysis (PD) fluid better preserves residual renal function in PD patients over time compared with conventional dialysate.</p&...
Main Authors: | Clarke Margaret, Johnson David W, Wilson Vanessa, Woods Feidhlim, Brown Fiona G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | BMC Nephrology |
Online Access: | http://www.biomedcentral.com/1471-2369/11/25 |
Similar Items
-
A Case Study of ANZ Customer Relationship Management
by: Chieh-ju Tzeng, et al.
Published: (2012) -
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
by: Isbel Nicole M, et al.
Published: (2009-07-01) -
Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA)
by: Qian Zhou, et al.
Published: (2020-10-01) -
Synthesis of Catalyst Cobalt Impregnated on Activated Natural Zeolite, Co/ANZ
by: Tri Kurnia Dewi, et al.
Published: (2017-02-01) -
A Study of Foreign Bank Acquisition Strategy-The Case of ANZ Bank
by: I-Ling Chang Chien, et al.
Published: (2012)